SELLAS Share Price

SELLAS Share Price

NASDAQ: SLS | Small Cap | Healthcare
$14.12
-$0.68 (-4.59%) Last updated on 21 Nov, 2026 | 03:08 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

SELLAS Stock Performance

Open
$14.99
Prev. Close
$14.80
Circuit Range
N/A
Day Range
$13.38 - $15.11
Year Range
$1.40 - $24.87
Volume
5,44,483
Average Traded
$13.85

SELLAS Share Price Today

As of 21 November 2026, SELLAS Life Sciences Group, Inc.'s share price is $14.12. The stock opened at $14.99, compared to its previous close of $14.80. During today's trading session, SELLAS Life Sciences Group, Inc.'s share price traded between $13.38 and $15.11, with an average price of $14.25. Over the past 52 weeks, the stock has recorded a high of $24.87 and a low of $1.40. In terms of performance, SELLAS Life Sciences Group, Inc.'s share price has risen by 51.75% over the last six months and is up 768.92% on a year-on-year basis.

SELLAS Share Price Chart

Line chart of the SELLAS price trend over the selected period. The price fell overall, ranging from 13.41 to 15.00, ending at 13.65.
$13.38$15.11
L
Show Current Price
H

SELLAS Stock Fundamentals & Key Indicators

Market Cap
$1.54B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.18
Revenue (TTM)
$0.00
Return On Equity (TTM)
-27.13%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-31.72%

SELLAS Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$7.66-$8.41-$9.61-$10.09
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-9.79%-14.27%-4.99%

SELLAS Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.00$0.00$0.00$0.00
Net Profit-$41.30-$37.34-$30.88-$26.86
Net Profit Margin-4130.00%N/AN/AN/A
Income ChangeN/A9.59%17.30%13.02%

SELLAS Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets3.133.113.053.19
Current Assets75.2116.333.1717.76
Total Assets78.3519.436.2220.94
Non Current Liabilities0.460.460.460.58
Current Liabilities7.029.5113.7415.52
Total Liabilities7.479.9714.216.09
Shareholders' Equity70.879.47-7.984.85

SELLAS Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-28.39-35.4-31.41-28.31
Investing0.00.0-5.50.0
Financing86.346.7622.3224.08

Corporate Actions

Split
Ex-date: 08 Nov 2019

About SELLAS

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

SELLAS Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$9.66
$13.67
+41.15%
Oct 2026
$12.16
$9.69
-21.55%
Sep 2026
$13.07
$12.35
-18.78%
Aug 2026
$9.94
$15.20
+52.08%
Jul 2026
$14.06
$9.99
-32.33%
Jun 2026
$9.09
$14.77
+58.73%
May 2026
$4.93
$9.30
+88.74%
Apr 2026
$4.28
$4.93
+16.82%
Mar 2026
$4.67
$4.22
-14.66%
Feb 2026
$3.69
$4.95
+31.17%
Jan 2026
$4.39
$3.77
-0.40%
Dec 2025
$1.58
$3.79
+132.92%

SELLAS Share Price FAQs